For decades, clinicians have noted that women face greater risks of multiple sclerosis (MS) and Alzheimer’s disease (AD)—and report higher rates of cognitive symptoms during menopause. These sex-specific differences have resisted easy explanation. Hormones such as estrogen clearly play a role, but their decline does not fully account for why female brains appear more vulnerable to neuroinflammatory and neurodegenerative processes.

Now, researchers at UCLA Health have pinpointed a second, genetic layer to this disparity: a gene on the X chromosome that amplifies inflammatory signaling in the brain’s immune cells.

The new study, published in Science Translational Medicine , identifies Kdm6a as a master regulator of microglial activation. Females, who carry two X chromosomes rat

See Full Page